Sarepta Therapeutics | Vendas





Vendas Alterar Data
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Agios Pharmaceuticals USD 12.9M 450K 2025-09
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Amgen USD 9.56B 380M 2025-09
Biogen USD 2.53B 70M 2025-09
BioMarin Pharmaceutical USD 776M 49M 2025-09
Daiichi Sankyo JPY 558.11B 57.35B 2025-12
Eli Lilly USD 17.6B 2.04B 2025-09
Gilead Sciences USD 7.8B 700M 2025-09
Incyte USD 1.37B 310M 2025-09
Insmed USD 142M 34.6M 2025-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
Moderna USD 1.02B 878M 2025-09
Neurocrine Biosciences USD 794.9M 107.4M 2025-09
Pfizer USD 16.7B 2B 2025-09
PTC Therapeutics USD 211M 32.1M 2025-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 160M 6.5M 2025-09
Vertex Pharmaceuticals USD 3.08B 120M 2025-09


Sarepta Therapeutics Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.